Active Stocks
Thu Mar 28 2024 15:59:33
  1. Tata Steel share price
  2. 155.90 2.00%
  1. ICICI Bank share price
  2. 1,095.75 1.08%
  1. HDFC Bank share price
  2. 1,448.20 0.52%
  1. ITC share price
  2. 428.55 0.13%
  1. Power Grid Corporation Of India share price
  2. 277.05 2.21%
Business News/ Companies / Glenmark gets USFDA nod for anti-cholesterol drug
BackBack

Glenmark gets USFDA nod for anti-cholesterol drug

Glenmark has been granted final approval by the USFDA for Fenofibrate Capsules USP, 67 mg, 134 mg and 200 mg

Glenmark stock was trading at Rs869.20, up 0.74% on the BSE.Premium
Glenmark stock was trading at Rs869.20, up 0.74% on the BSE.

New Delhi: Drug firm Glenmark Pharmaceuticals Ltd on Monday said it has received final approval from the United States Food and Drug Administration (USFDA) for its generic version of Fenofibrate capsules used for lowering cholesterol.

The company has been granted final approval by the USFDA for Fenofibrate Capsules USP 67 mg, 134 mg and 200 mg, Glenmark Pharmaceuticals said in a statement.

The company’s product is the generic version of Tricor Micronized capsules, 67 mg, 134 mg, and 200 mg of AbbVie Inc, it added. Citing IMS Health February 2017, Glenmark said the Tricor Micronized capsules had annual sales of approximately $97.5 million.

The stock was trading at Rs869.20, up 0.74% on the Bombay Stock Exchange (BSE).

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 10 Apr 2017, 02:26 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App

Chat with MintGenie